Unilever says it will not raise offer for GSK division after £50bn bid rejected
Published
Unilever has said it will not increase its £50 billion offer for GlaxoSmithKline’s (GSK) consumer arm which was rejected earlier this week.
Full ArticlePublished
Unilever has said it will not increase its £50 billion offer for GlaxoSmithKline’s (GSK) consumer arm which was rejected earlier this week.
Full ArticleUnilever’s rejected £50bn offer for Glaxo Smith Kline’s (GSK) consumer business falls short according to market analysts...